Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

In vivo and in vitro models for the therapeutic targeting of Wnt signaling using a Tet-OΔN89β-catenin system.

Jardé T, Evans RJ, McQuillan KL, Parry L, Feng GJ, Alvares B, Clarke AR, Dale TC.

Oncogene. 2013 Feb 14;32(7):883-93. doi: 10.1038/onc.2012.103.

2.

A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.

Buchert M, Rohde F, Eissmann M, Tebbutt N, Williams B, Tan CW, Owen A, Hirokawa Y, Gnann A, Orend G, Orner G, Dashwood RH, Heath JK, Ernst M, Janssen KP.

Dis Model Mech. 2015 Nov;8(11):1361-73. doi: 10.1242/dmm.019844.

3.

Transgenic expression of oncogenic BRAF induces loss of stem cells in the mouse intestine, which is antagonized by β-catenin activity.

Riemer P, Sreekumar A, Reinke S, Rad R, Schäfer R, Sers C, Bläker H, Herrmann BG, Morkel M.

Oncogene. 2015 Jun 11;34(24):3164-75. doi: 10.1038/onc.2014.247.

PMID:
25109331
4.

SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.

Trautmann M, Sievers E, Aretz S, Kindler D, Michels S, Friedrichs N, Renner M, Kirfel J, Steiner S, Huss S, Koch A, Penzel R, Larsson O, Kawai A, Tanaka S, Sonobe H, Waha A, Schirmacher P, Mechtersheimer G, Wardelmann E, Büttner R, Hartmann W.

Oncogene. 2014 Oct 16;33(42):5006-16. doi: 10.1038/onc.2013.443.

PMID:
24166495
5.

Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer.

Heerma van Voss MR, Vesuna F, Trumpi K, Brilliant J, Berlinicke C, de Leng W, Kranenburg O, Offerhaus GJ, Bürger H, van der Wall E, van Diest PJ, Raman V.

Oncotarget. 2015 Sep 29;6(29):28312-26. doi: 10.18632/oncotarget.4873.

6.

The E6 oncoprotein from HPV16 enhances the canonical Wnt/β-catenin pathway in skin epidermis in vivo.

Bonilla-Delgado J, Bulut G, Liu X, Cortés-Malagón EM, Schlegel R, Flores-Maldonado C, Contreras RG, Chung SH, Lambert PF, Uren A, Gariglio P.

Mol Cancer Res. 2012 Feb;10(2):250-8. doi: 10.1158/1541-7786.MCR-11-0287.

8.

Wnt/β-Catenin Signaling Mediates Regeneration of Retinal Pigment Epithelium After Laser Photocoagulation in Mouse Eye.

Han JW, Lyu J, Park YJ, Jang SY, Park TK.

Invest Ophthalmol Vis Sci. 2015 Dec;56(13):8314-24. doi: 10.1167/iovs.15-18359.

PMID:
26720485
10.

Wnt/β-catenin pathway regulates bone morphogenetic protein (BMP2)-mediated differentiation of dental follicle cells.

Silvério KG, Davidson KC, James RG, Adams AM, Foster BL, Nociti FH Jr, Somerman MJ, Moon RT.

J Periodontal Res. 2012 Jun;47(3):309-19. doi: 10.1111/j.1600-0765.2011.01433.x.

11.

Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.

Ma L, Wang X, Jia T, Wei W, Chua MS, So S.

Oncotarget. 2015 Sep 22;6(28):25390-401. doi: 10.18632/oncotarget.4455.

12.

OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.

Ye GD, Sun GB, Jiao P, Chen C, Liu QF, Huang XL, Zhang R, Cai WY, Li SN, Wu JF, Liu YJ, Wu RS, Xie YY, Chan EC, Liou YC, Li BA.

Gastroenterology. 2016 Mar;150(3):659-671.e16. doi: 10.1053/j.gastro.2015.11.041.

PMID:
26619963
13.

A mouse transgenic approach to induce β-catenin signaling in a temporally controlled manner.

Mukherjee A, Soyal SM, Li J, Ying Y, Szwarc MM, He B, Kommagani R, Hodgson MC, Hiremath M, Cowin P, Lydon JP.

Transgenic Res. 2011 Aug;20(4):827-40. doi: 10.1007/s11248-010-9466-6.

PMID:
21120693
14.

Dose-dependent roles for canonical Wnt signalling in de novo crypt formation and cell cycle properties of the colonic epithelium.

Hirata A, Utikal J, Yamashita S, Aoki H, Watanabe A, Yamamoto T, Okano H, Bardeesy N, Kunisada T, Ushijima T, Hara A, Jaenisch R, Hochedlinger K, Yamada Y.

Development. 2013 Jan 1;140(1):66-75. doi: 10.1242/dev.084103.

15.

A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression.

Zeineldin M, Cunningham J, McGuinness W, Alltizer P, Cowley B, Blanchat B, Xu W, Pinson D, Neufeld KL.

Oncogene. 2012 May 10;31(19):2423-37. doi: 10.1038/onc.2011.434.

16.

MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.

Wu G, Liu A, Zhu J, Lei F, Wu S, Zhang X, Ye L, Cao L, He S.

Oncotarget. 2015 Oct 6;6(30):28882-94. doi: 10.18632/oncotarget.4921.

17.

Phases of canonical Wnt signaling during the development of mouse intestinal epithelium.

Kim BM, Mao J, Taketo MM, Shivdasani RA.

Gastroenterology. 2007 Aug;133(2):529-38.

PMID:
17681174
18.

Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regeneration.

Phesse TJ, Buchert M, Stuart E, Flanagan DJ, Faux M, Afshar-Sterle S, Walker F, Zhang HH, Nowell CJ, Jorissen R, Tan CW, Hirokawa Y, Eissmann MF, Poh AR, Malaterre J, Pearson HB, Kirsch DG, Provero P, Poli V, Ramsay RG, Sieber O, Burgess AW, Huszar D, Vincan E, Ernst M.

Sci Signal. 2014 Sep 30;7(345):ra92. doi: 10.1126/scisignal.2005411.

PMID:
25270258
19.

Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson's disease.

Zhou T, Zu G, Zhang X, Wang X, Li S, Gong X, Liang Z, Zhao J.

Neuropharmacology. 2016 Feb;101:480-9. doi: 10.1016/j.neuropharm.2015.10.024.

PMID:
26525190
20.

Ectopic activation of Wnt/β-catenin signaling in lens fiber cells results in cataract formation and aberrant fiber cell differentiation.

Antosova B, Smolikova J, Borkovcova R, Strnad H, Lachova J, Machon O, Kozmik Z.

PLoS One. 2013 Oct 30;8(10):e78279. doi: 10.1371/journal.pone.0078279.

Items per page

Supplemental Content

Support Center